Advertisement

Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016

  • Roberta RudàEmail author
  • Alessia Pellerino
  • Andrea Pace
  • Carmine Maria Carapella
  • Cristina Dealis
  • Manuela Caroli
  • Marina Faedi
  • Lorenzo Bello
  • Enrica Migliore
  • Giulia Marchese
  • Luca Bertero
  • Paola Cassoni
  • Riccardo Soffietti
Correction
  • 102 Downloads

Correction to: Journal of Neuro-Oncology (2019) 145:115–123 https://doi.org/10.1007/s11060-019-03277-x

The third and fourth authors' affiliation was incorrectly specified in the original publication. It is correctly shown here.

Notes

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Roberta Rudà
    • 1
    Email author
  • Alessia Pellerino
    • 1
  • Andrea Pace
    • 2
  • Carmine Maria Carapella
    • 2
  • Cristina Dealis
    • 3
  • Manuela Caroli
    • 4
  • Marina Faedi
    • 5
  • Lorenzo Bello
    • 6
  • Enrica Migliore
    • 7
  • Giulia Marchese
    • 1
  • Luca Bertero
    • 8
  • Paola Cassoni
    • 8
  • Riccardo Soffietti
    • 1
  1. 1.Department of Neuro‑OncologyUniversity and City of Health and Science HospitalTurinItaly
  2. 2.Department of NeurosurgeryI.R.C.C.S. Regina Elena National Cancer InstituteRomeItaly
  3. 3.Department of Medical OncologyRegional HospitalBolzanoItaly
  4. 4.Department of NeurosurgeryRegional HospitalMilanItaly
  5. 5.Department of Medical OncologyRegional HospitalCesenaItaly
  6. 6.Department of NeurosurgeryUniversity of MilanMilanItaly
  7. 7.Unit of Cancer Epidemiology (CPO Piemonte)University of TurinTurinItaly
  8. 8.Department of Biomedical SciencesUniversity and City of Health and Science HospitalTurinItaly

Personalised recommendations